uniQure N.V.
corporate_fare Company Profile
uniQure N.V. (NASDAQ:QURE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 35 items for QURE at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- FDA Accepts Phase 1/2 Data for uniQure's AMT-130 BLA, Plans Q3 Submission
- Shareholders Approve Major Increase in Authorized Shares and Incentive Plan, Boosting Potential Dilution
- uniQure Reports Increased Loss, Pursues UK Regulatory Path for AMT-130 Amidst Clinical Setbacks
- uniQure's Lead HD Program AMT-130 Faces FDA Setback, ALS Program Discontinued Amid Q1 Loss; Strong Cash Runway Maintained
- 75% Disease Slowing: uniQure's AMT-130 Nears UK Submission for Huntington's
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$16.1M
Net Income
-$198.97M
Diluted EPS
-$3.46
Op. Cash Flow
-$177.96M
Free Cash Flow
-$178.4M
Gross Profit
$14.41M
Operating Income
-$185.35M
Cash & Equivalents
$80.24M
Total Debt
$49.7M
Debt / Equity
0.25×
Net Margin
-12.36×
Shares Outstanding
62.34M sh
Source: 10-K · filed 2026-03-02 · accession 0001104659-26-021898
show_chartPrice Chart
Loading chart...
feed QURE - Filings & News (Page 2)
QURE
Jun 17, 2026, 7:05 AM EDT
Price at Filing:
$27.50
Real-time Price:
$20.12
Change:
-$7.38 (-27%)
Market Cap:
$1.357B
QURE
Jun 15, 2026, 4:30 PM EDT
Price at Filing:
$27.87
Real-time Price:
$20.12
Change:
-$7.75 (-28%)
Market Cap:
$1.357B
QURE
May 05, 2026, 7:15 AM EDT
Price at Filing:
$20.89
Real-time Price:
$20.12
Change:
-$0.770 (-4%)
Market Cap:
$1.357B
QURE
May 05, 2026, 7:06 AM EDT
Price at Filing:
$20.89
Real-time Price:
$20.12
Change:
-$0.770 (-4%)
Market Cap:
$1.357B
QURE
Apr 30, 2026, 7:05 AM EDT
Price at Filing:
$17.75
Real-time Price:
$20.12
Change:
+$2.37 (+13%)
Market Cap:
$1.357B
QURE
Apr 27, 2026, 7:00 AM EDT
Price at Filing:
$18.53
Real-time Price:
$20.12
Change:
+$1.59 (+9%)
Market Cap:
$1.357B
QURE
Apr 16, 2026, 5:00 PM EDT
Price at Filing:
$16.82
Real-time Price:
$20.12
Change:
+$3.30 (+20%)
Market Cap:
$1.357B
QURE
Mar 23, 2026, 9:40 PM EDT
Securities Fraud Lawsuit Filed Against uniQure N.V. Over 49% Stock Drop Following FDA Approval Delay
Price at Filing:
$15.62
Real-time Price:
$20.12
Change:
+$4.50 (+29%)
Market Cap:
$1.357B
QURE
Mar 03, 2026, 5:30 AM EST
Price at Filing:
$10.12
Real-time Price:
$20.12
Change:
+$10.00 (+99%)
Market Cap:
$1.357B
QURE
Mar 02, 2026, 7:24 AM EST
Price at Filing:
$8.65
Real-time Price:
$20.12
Change:
+$11.47 (+133%)
Market Cap:
$1.357B
QURE
Mar 02, 2026, 7:09 AM EST
Price at Filing:
$9.20
Real-time Price:
$20.12
Change:
+$10.92 (+119%)
Market Cap:
$1.357B
QURE
Mar 02, 2026, 7:06 AM EST
Price at Filing:
$8.99
Real-time Price:
$20.12
Change:
+$11.13 (+124%)
Market Cap:
$1.357B
QURE
Feb 26, 2026, 9:20 PM EST
Price at Filing:
$16.82
Real-time Price:
$20.12
Change:
+$3.30 (+20%)
Market Cap:
$1.357B
QURE
Jan 13, 2026, 7:05 AM EST
Price at Filing:
$21.54
Real-time Price:
$20.12
Change:
-$1.42 (-7%)
Market Cap:
$1.357B
QURE
Jan 09, 2026, 7:06 AM EST
Price at Filing:
$24.49
Real-time Price:
$20.12
Change:
-$4.37 (-18%)
Market Cap:
$1.357B